Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DPC 2024
Programm
Suche
DE
Alle Personen
Prof. Dr. Julia Mayerle
München / DE
Sortiert nach Typ
Datum
Vortrag
Fr, 16.02.
14:35
–
14:45
5 Min.
5 Min.
Oral presentation
Non-invasive cancer monitoring
Weitere Beteiligungen
Do, 15.02.
14:00
–
14:10
8 Min.
2 Min.
Oral presentation
O01
Context-dependent role of acid sphingomyelinase in pancreatic ductal adenocarcinoma
Pancreatic cancer
Do, 15.02.
16:05
–
16:10
3 Min.
2 Min.
ePoster presentation
P02
Long-term safety and efficacy outcomes of RTX in the different IgG4-RD phenotypes
Acute/chronic pancreatitis
Do, 15.02.
16:50
–
16:55
3 Min.
2 Min.
ePoster presentation
P11
Epigenetic priming of pancreatic acinar cells by inflammation promotes tissue regeneration after recurrent pancreatitis
Acute/chronic pancreatitis
Fr, 16.02.
14:15
–
14:20
3 Min.
2 Min.
ePoster presentation
P23
Evaluation of the quality of life in a prospective, longitudinal cohort of patients with pancreatic cancer
Pancreatic cancer
Fr, 16.02.
14:35
–
14:40
3 Min.
2 Min.
ePoster presentation
P38
First episode of idiopathic acute pancreatitis does not lead to more severe pancreatitis outcome compared to first time monocausally triggered pancreatitis
Acute/chronic pancreatitis
Fr, 16.02.
15:00
–
15:05
3 Min.
2 Min.
ePoster presentation
P32
Severity of gallstone, sludge or microlithiasis induced pancreatitis – all of the same?
Acute/chronic pancreatitis
Fr, 16.02.
17:25
–
17:35
8 Min.
2 Min.
Oral presentation
O36
Mouse model of biliary pancreatitis: The stepping stone to understand human biliary pancreatitis
Acute/chronic pancreatitis
Fr, 16.02.
18:05
–
18:15
8 Min.
2 Min.
Oral presentation
O40
DRACULA – drainage and flushing therapy in necrotizing pancreatitis; a retrospective, multicentric study
Acute/chronic pancreatitis
Sa, 17.02.
09:50
–
10:00
8 Min.
2 Min.
Oral presentation
O52
PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents
Acute/chronic pancreatitis
Sa, 17.02.
10:00
–
10:05
3 Min.
2 Min.
ePoster presentation
P55
In vitro modeling of cancerous neural invasion: The Celiac Ganglia Model
Pancreatic cancer
Sa, 17.02.
10:25
–
10:30
3 Min.
2 Min.
ePoster presentation
P49
Influence of cancer associated fibroblasts (CAFs) heterogeneity on shaping immunosuppressive tumor microenvironment in PDAC
Pancreatic cancer
Sa, 17.02.
11:00
–
11:05
3 Min.
2 Min.
ePoster presentation
P76
Deciphering immunothrombosis in chronic pancreatitis: An in-depth metabolome exploration
Acute/chronic pancreatitis
Sa, 17.02.
11:00
–
11:05
3 Min.
2 Min.
ePoster presentation
P65
Adrenergic signaling in pancreatic cancer metastasis
Pancreatic cancer
Sa, 17.02.
11:05
–
11:10
3 Min.
2 Min.
ePoster presentation
P77
Depletion of α-SMA+ myofibroblast aggravates pancreatitis in mice
Acute/chronic pancreatitis
Sa, 17.02.
11:35
–
11:40
3 Min.
2 Min.
ePoster presentation
P83
The T-reg attracting chemokine CCL1 potently discriminates between acute pancreatitis and sepsis
Acute/chronic pancreatitis
Sa, 17.02.
13:00
–
13:10
8 Min.
2 Min.
Oral presentation
O56
Irf3 and Irf7 are crucial factors for controlling a tumor-promoting epigenetic program
Pancreatic cancer
Sa, 17.02.
13:10
–
13:20
8 Min.
2 Min.
Oral presentation
O57
Expression of Lysine Demethylase 5a (
Kdm5a
) affects metabolic activity and aggressiveness of murine pancreatic cancer cells
Tumour microenvironment, epigenetics and stem cells
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz